FIELD: medicinal and chemical-pharmaceutical industry, veterinary science. SUBSTANCE: composition has hydrolytic lignin, polyvinylpyrrolidone and calcium stearate. In the process of tablets making hydrolytic lignin is wetted with 22% aqueous solution of polyvinylpyrrolidone. Obtained mass is subjected for wet granulation followed by drying and tabletting. EFFECT: increased adsorption capacity of tablets as compared with parent hydrolytic lignin. 3 cl
